Quarterly Report

BIODESIX INC Filed 2025-05-13 Acc 0000950170-25-070339

Documents 1

2025-08-07 10-Q Quarterly Report
2025-05-13 10-Q Quarterly Report
2025-05-13 4 Chief Accounting Officer sold 224 shares at an average $0.36 ($80)
2025-05-13 4 Chief Development Officer sold 445 shares at an average $0.36 ($158)
2025-05-13 4 Chief Commercial Officer sold 477 shares at an average $0.36 ($170)
2025-05-13 4 President & CEO sold 3,775 shares at an average $0.36 ($1,344)
2024-11-01 10-Q Quarterly Report

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading bdsx-20250331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…